Reduction in proteinuria with bortezomib based therapy for antibody mediated rejection

Clin Transpl. 2010:437-40.
No abstract available

MeSH terms

  • Adult
  • Biopsy
  • Boronic Acids / therapeutic use*
  • Bortezomib
  • Female
  • Graft Rejection / immunology
  • Graft Rejection / pathology
  • Graft Rejection / prevention & control*
  • Graft Survival / drug effects*
  • HLA Antigens / immunology*
  • Humans
  • Immunity, Humoral / drug effects
  • Immunosuppressive Agents / therapeutic use*
  • Isoantibodies / blood*
  • Kidney Transplantation / immunology*
  • Male
  • Middle Aged
  • New York City
  • Protease Inhibitors / therapeutic use*
  • Proteasome Endopeptidase Complex / metabolism
  • Proteasome Inhibitors
  • Proteinuria / drug therapy*
  • Proteinuria / immunology
  • Proteinuria / pathology
  • Pyrazines / therapeutic use*
  • Retrospective Studies
  • Salvage Therapy
  • Time Factors
  • Treatment Outcome

Substances

  • Boronic Acids
  • HLA Antigens
  • Immunosuppressive Agents
  • Isoantibodies
  • Protease Inhibitors
  • Proteasome Inhibitors
  • Pyrazines
  • Bortezomib
  • Proteasome Endopeptidase Complex